US regulatory status: approved. Molecular target: Estrogen receptor.
- Target
- Estrogen receptor
- Mechanism
- Estrogen receptor alpha agonist
pharma · Neurogenic Orthostatic Hypotension
HAC Pharma
H.A.C. Pharma
HAC Pharma drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Caen, FR HQ
2007 Founded
51 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Caen, FR
- Founded
- 2007
- Employees
- 51
- Programs
- 1
- Drugs
- 2
- Patents
- 0
HAC Pharma pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
HAC Pharma drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
orlistat
Alimentary tract and metabolism (A08)US regulatory status: approved. Molecular target: Gastric triacylglycerol lipase.
- Target
- Gastric triacylglycerol lipase
- Mechanism
- Pancreatic lipase inhibitor